Brief: Neurosense Therapeutics Reports Positive Preliminary Results In Parkinson's Biomarker Study
02/05/2023 13:32
May 2 (Reuters) - Neurosense Therapeutics Ltd NRSN.O :
* NEUROSENSE THERAPEUTICS REPORTS POSITIVE PRELIMINARY
RESULTS IN
PARKINSON'S BIOMARKER STUDY
* NEUROSENSE THERAPEUTICS LTD - EXPLORING CO-DEVELOPMENT OF
PD
ASSET WITH POTENTIAL COLLABORATORS
* NEUROSENSE-IN PD BIOMARKER STUDY, SAW STATISTICALLY
SIGNIFICANT
DECREASE IN LEVELS OF AGO2 IN NEWLY DIAGNOSED PD PATIENTS VERSUS
HEALTHY CONTROL GROUP
Source text for Eikon: ID:nPntKpNQa
Further company coverage: NRSN.O
((Reuters.Briefs@thomsonreuters.com;))